Performance Improvement 2011-2012. How Does Ryan White Care Act Funding Impact Service Use and Patient Health for Those Suffering from Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome?


This study examined the impact of Title I funds on service utilization patterns and prevalence of HIV-related morbidity and mortality among underserved and vulnerable populations in two metropolitan areas It compared delivery and utilization of HIV-related services before (Phase 1: 3/1/1998-2/28/1999) and after (Phase 2: 3/1/2000-2/28/2001) the receipt of Ryan White CARE Act funding.   

Both study sites reported that 100 percent of patients were prescribed antiretroviral therapy at least once every three months, regardless of clinic type in Phase 2 compared to 63 percent in Phase 1.


Report Title: Impact of RWCA Title I Funding on HIV Services Utilization and Health Outcomes in Newly Eligible Metropolitan Areas (EMAs)
Agency Sponsor: HRSA, Health Resources and Services Administration
Federal Contact: Malitz, Faye, 301-443-3259
Performer: Health Resources and Services Administration

Record ID: 7215 (Report issued January 31, 2010)

View full report


"PerformanceImprovement2011-2012.pdf" (pdf, 701.44Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®